Person: GEBİTEKİN, CENGİZ
Loading...
Email Address
Birth Date
Research Projects
Organizational Units
Job Title
Last Name
GEBİTEKİN
First Name
CENGİZ
Name
27 results
Search Results
Now showing 1 - 10 of 27
Publication Diagnostic value of cervical mediastinoscopy: Report of 506 cases(European Respiratory, 2013-09-01) Erol, Mehmet; Melek, Hüseyin; Bayram, Ahmet; Kermenli, Tayfun; Coşkun, Funda; Akyıldız, Elif; Gebitekin, Cengiz; Erol, Mehmet; MELEK, HÜSEYİN; BAYRAM, AHMET SAMİ; Kermenli, Tayfun; COŞKUN, NECMİYE FUNDA; AKYILDIZ, ELİF ÜLKER; GEBİTEKİN, CENGİZ; Tıp Fakültesi; Göğüs Hastalıkları Bölümü; 0000-0003-0684-0900; 0000-0002-7371-4026; 0000-0003-3604-8826; AAE-1069-2022; AAD-1271-2019; AAI-5039-2021; JCE-0097-2023; ABB-7580-2020; KHO-7454-2024; A-6612-2019; IAV-7890-2023Publication Simultaneous repair of pectus deformities and atrial septal defect(Springer India, 2005-06-01) Bayram, Ahmet Sami; BAYRAM, AHMET SAMİ; Şenkaya, Işık; ŞENKAYA SIĞNAK, IŞIK; Gebitekin, Cengiz; GEBİTEKİN, CENGİZ; Tıp Fakültesi; Genel Cerrahi Ana Bilim Dalı; 0000-0003-0684-0900; ABB-7580-2020; AAE-1069-2022; JCE-0097-2023Publication Thymic tumors and outcomes after radiotherapy(Kare Yayın, 2013-01-01) Sarıhan, Süreyya; Bayram, Ahmet Sami; Gebitekin, Cengiz; Yerci, Ömer; Özkan, Lütfi; SARIHAN, SÜREYYA; BAYRAM, AHMET SAMİ; GEBİTEKİN, CENGİZ; YERCİ, ÖMER; Özkan, Lütfi; Tıp Fakültesi; Göğüs Cerrahisi Ana Bilim Dalı; 0000-0003-4816-5798; 0000-0003-0684-0900; AAE-1069-2022; ABB-7580-2020; AAH-4970-2021; EIS-5114-2022; JGQ-9310-2023OBJECTIVESWe evaluated the results of treatment in patients with thymic tumors treated with postoperative adjuvant radiotherapy.METHODSEighteen patients were treated median 5400 cGy radiotherapy between 1995-2010. Diagnosis of patients were thymoma (n=10), thymic carcinoma (n=7), thymic neuroendocrin carcinoma (n=1). RO resection was made on 12 of them. According to prognostic stratification with Masaoka stage and WHO classification, there were 5 good, 7 moderate, and 6 poor risk patients. Survival was calculated from diagnosis.RESULTSA total of 33% patients were recurred median 29.5 months with 34 months follow-up. Local control, median overall and disease-free survival for all patients were 77%, 113 months, and 105 months. Local control for good, moderate, poor risk groups were found 100%, 71%, 50%. There were significant differences survival rates for Masaoka stage, RO resection, and prognostic groups.CONCLUSIONPrognostic risk classification was found to be better predictive in terms of local control and survival.Publication Comparison of survival results of patients with t0 and t1-2-3 in pathological t staging in patients with non-small cell lung cancer who underwent surgery after neoadjuvant treatment(Termedia Publishing House, 2020-01-01) Kermenli, Tayfun; Melek, Hüseyin; Bayram, Ahmet Sami; Gebitekin, Cengiz; MELEK, HÜSEYİN; BAYRAM, AHMET SAMİ; GEBİTEKİN, CENGİZ; Tıp Fakültesi; 0000-0003-0684-0900; 0000-0003-1822-8153; AAE-1069-2022; AAI-5039-2021; JCE-0097-2023; ABB-7580-2020Aim: In this study, we aimed to compare the survival results of patients who underwent neoadjuvant treatment with NSCLC between March 1997 and August 2014 and were found to have T0N0 and T1-2-3/N0.Material and methods: A hundred ninety-five patients who had complete neoadjuvant therapy, complete lung resection and lymph node dissection, and pathologically diagnosed as T0 or T1-2-3/N0, M0 were included in the study.Results: Of the 195 patients included in the study, 181 were male, 14 were female and the mean age of the patients was 57.9. The mean age of the groups was as follows: group 1: 58.1, group 2: 57.7, group 3: 59.7 and group 4: 56.8. In our series the most common complication was atelectasis (n = 19). Others were prolonged air leak (n = 16), pneumonia (n = 12), apical pleural space (n = 6), wound infection (n = 3), cardiac problems (n = 3), hematoma (n = 3), bronchopleural fistula (n = 3), empyema (n = 2), chylothorax (n = 1). The 5-year survival rate for patients in the T0N0 group was 76.3%. This rate was 71.8% in group 2, 63.6% in group 3 and 44.1% in group 4.Conclusions: Survival was found to be better in patients who underwent surgery after neoadjuvant therapy and had a complete pathological response. We believe that we can provide better results with the increase in the number of cases detected as TxN0 after the neoadjuvant treatment and prolongation of the follow-up period.Publication Gastrointestinal stromal tumor of the esophagus: Report of a case(Derman Medical Publ, 2016-01-01) GEBİTEKİN, CENGİZ; Erol, M. Muharrem; Melek, Huseyin; MELEK, HÜSEYİN; BAYRAM, AHMET SAMİ; Akyıldız, Elif Ülker; AKYILDIZ, ELİF ÜLKER; Tıp Fakültesi; Göğüs Cerrahisi Ana Bilim Dalı; 0000-0003-0684-0900; ABB-7580-2020; AAI-5039-2021; JCE-0097-2023; AAE-1069-2022Gastrointestinal stromal tumors are rare neoplasms to be thought to arise from mesenchymal cells of the gastrointestinal tract. Gastrointestinal stromal tumors (GIST) of the esophagus am weIl documented but are very much rarer than gastrointestinal stronmI tumors of the stomach and small [voted, We describe a case of GIST of the esophagus that was resected With wide surgical resection.Publication Evaluation of prognostic factors on survival in non-small-cell lung cancer patients treated with postoperative radiotherapy(Kare Publ, 2009-01-01) Sarıhan, Süreyya; SARIHAN, SÜREYYA; Gebitekin, Cengiz; ERCAN, İLKER; GEBİTEKİN, CENGİZ; Bayram, Ahmet Sami; BAYRAM, AHMET SAMİ; EVRENSEL, TÜRKKAN; Evrensel, Turkkan; Akyıldız, Elif Ülker; AKYILDIZ, ELİF ÜLKER; Tıp Fakültesi; Biyoistatistik Ana Bilim Dalı; 0000-0003-4816-5798; 0000-0003-0684-0900; 0000-0002-2382-290X; ABB-7580-2020; AAJ-1027-2021; JCE-0097-2023; AAH-4970-2021; AAE-1069-2022OBJECTIVESTo investigate the prognostic factors on survival in non-small-cell lung cancer patients treated with postoperative radiotherapy.METHODSSixty-five patients treated with a median dose of 59 Gy (50-66.6 Gy) between October 1995 and January 2005 were included in the study. Clinical and categorical variables were analyzed.RESULTSOn multivariate analysis, presence of clinical N2 and brain metastasis at first relapse and absence of chemotherapy (p=0.02, p=0.004, p=0.004) had a negative impact on overall survival, while presence of pathological nodal involvement and absence of chemotherapy (p=0.02, p=0.04) were effective on disease-free survival. Regarding categorical variables, type of resection was found related with positive margin and N1, right-sided location with N1-e and N2, and systematic nodal dissection with N1. The number of involved lymph nodes was found related with N2 skip metastasis and involved N1-10 was related with N1-e.CONCLUSIONPresence of metastatic lymph nodes was found to be a poor prognostic factor and delivery of chemotherapy was seen to positively affect overall and disease-free survival rates.Publication Can thoracic sympathetic nerve damage be reversed?(Georg Thieme Verlag, 2015-12-01) Erol, M. Muharrem; Salcı, Hakan; Melek, Hüseyin; İlhan, Tuncay; Özfiliz, Nesrin; Bayram, Ahmet Sami; Gebitekin, Cengiz; Erol, M. Muharrem; SALCI, HAKAN; MELEK, HÜSEYİN; İLHAN, TUNCAY; ÖZFİLİZ, NESRİN; BAYRAM, AHMET SAMİ; GEBİTEKİN, CENGİZ; Veteriner Fakültesi; Cerrahi Ana Bilim Dalı; 0000-0003-0684-0900; 0000-0003-1822-8153; AAI-5039-2021; AAE-1069-2022; AAH-2756-2021; JCE-0097-2023; AAH-8859-2021; ABB-7580-2020; T-4623-2019; KHE-8874-2024Background Function of the thoracic sympathetic chain (TSC) reportedly recovers after surgical clips are removed. Hence, this study was designed to study nerve regeneration after unclipping the TSC.Methods The bilateral TSCs of six goats were studied; the goats were separated into three groups (groups I, II, and III) during excision, clipping, and unclipping. During surgery, the TSCs were excised with a scalpel in group I and clipped in groups II and III. In group III, the clips were removed 1 month postoperatively and observed for possible nerve healing for 1 month. All TSCs were examined histologically following en block resection at 1 month postoperatively in groups I and II and at 2 months postoperatively in group III.Results Inflammation in nerve sections was noted following clip removal. Furthermore, there was significant degeneration and cell infiltration in the nerve fibers of the clipped regions. The Schwann cells around the peripheral nerve endings in the unclipped regions facilitated nerve transmission by reconstitution of myelin.Conclusion Clipping the TSC can cause histologic degeneration; however, histologic nerve regeneration occurs after unclipping.Publication Thoracoscopic bullectomy and pleural abrasion in the treatment of primary spontaneous pneumothorax(Turkish Assoc Tuberculosis & Thorax, 2008-01-01) Bayram, Ahmet Sami; Erol, Muharrem; Kaya, Fatma Nur; Özcan, Metin; Koprücüoğlu, Mustafa; Gebitekin, Cengiz; BAYRAM, AHMET SAMİ; Erol, Muharrem; KAYA, FATMA NUR; Özcan, Metin; Koprücüoğlu, Mustafa; GEBİTEKİN, CENGİZ; Tıp Fakültesi; Göğüs Cerrahisi Ana Bilim Dalı; 0000-0003-0684-0900; AAE-1069-2022; AAI-8213-2021; JCE-0097-2023; ABB-7580-2020; JEN-3243-2023; JKB-5632-2023; FGE-6493-2022Although spontaneous pneumothorax is the most common problem seen by the thoracic surgeon, there is no universal agreement in its management. Thoracoscopic bullectomy is preferred to open bullectomy because of minimal trauma, less pain, early recovery and discharge with comparable results. Seventy thoracoscopic bullectomy and apical pleural abrasion in 65 patients with spontaneous pneumothorax were retrospectively reviewed. All but 8 (13%) patients were male with a mean age of 24 years (range 17-55). Only the patients who had a prolonged air leak (> 4 days), reccurence/ bilateral pneumothorax occupational reasons and bilateral pneumothorax were the indications for surgical treatment. The patients who had conversion to open thoracotomy were not included in the study. Computerized tomography was performed in all cases prior to the surgery. Endo-GIA 45-60 mm (4.8) staplers (Auto Suture, Tyco, USA) were used for bullectomy using three port access. The apical pleural abrasion following thoracoscopic bullectomy was performed in all cases. One patient developed haematoma on the first postoperative day and underwent open thoracotomy and evacuation of the haematoma. The median hospital stay was 3 (1-11) days. Recurrent pneumothorax was observed in 5 (7.1%) patients. Although thoracoscopic bullectomy is an expensive procedure that requires experience, however reduced pain, shorter hospital stay and early recovery makes it preferred method in such cases.Publication Vats lobectomy and chest wall resection for NSCLC(Elsevier, 2019-10-01) Melek, Hüseyin; Özkan, B.; Kara, H.; Kaba, E.; Bayram, A.; Ülker, M.; Ersen, E.; Turna, A.; Toker, A.; Gebitekin, Cengiz; MELEK, HÜSEYİN; GEBİTEKİN, CENGİZ; Tıp Fakültesi; Göğüs Cerrahisi Ana Bilim Dalı; AAI-5039-2021; AAE-1069-2022Publication Minimally invasive approaches for en-bloc anatomical lung and chest wall resection(Baycinar Medical Publ-Bayçınar Tıbbı Yayıncılık, 2023-07-01) Melek, Hüseyin; Özkan, Berker; Kara, Hasan Volkan; Sevinc, Tolga Evrim; Kaba, Erkan; Turna, Akif; Toker, Alper; Gebitekin, Cengiz; MELEK, HÜSEYİN; SEVİNÇ, TOLGA EVRİM; GEBİTEKİN, CENGİZ; Tıp Fakültesi; Göğüs Cerrahisi Ana Bilim Dalı; 0000-0003-1822-8153 ; AAI-5039-2021; IGQ-1108-2023; JCE-0097-2023Background: The aim of this study was to evaluate the feasibility of en-bloc anatomical lung and chest wall resection via minimally invasive surgery.Methods: Between January 2013 and December 2021, a total of 22 patients (18 males, 4 females; mean age: 63 & PLUSMN;6.9 years; range, 48 to 78 years) who underwent anatomical lung and chest wall resection using minimally invasive surgery for non-small cell lung cancer were retrospectively analyzed. Demographic, clinical, intra-and postoperative data of the patients, recurrence, metastasis, mortality, and overall survival rates were recorded.Results: The surgical technique was robot-assisted thoracic surgery in two, multiport video-assisted thoracoscopic surgery in 18, and uniport video-assisted thoracoscopic surgery in two patients. Upper lobectomy was performed in 17 (77.3%) patients, lower lobectomy in three (13.6%) patients, and upper lobe segmentectomy in two (9.1%) patients. Five different techniques were used for chest wall resection. Nine (40.9%) patients had one, eight (36.4%) patients had two, four (18.2%) patients had three, and one (4.5%) patient had four rib resections. Chest wall reconstruction was necessary for only one of the patients. The mean operation time was 114 & PLUSMN;36.8 min. Complete resection was achieved in all patients. Complications were observed in seven (31.8%) patients without mortality. The mean follow-up was 24.4 & PLUSMN;17.9 months. The five-year overall survival rate was 55.3%. Conclusion: Segmentectomy/lobectomy and chest wall resection with minimally invasive surgery are safe and feasible in patients with non -small cell lung cancer. In addition, the localization of the area where chest wall resection would be performed should be considered the most crucial criterion in selecting the ideal technique.
- «
- 1 (current)
- 2
- 3
- »